CDC Shifts Rotavirus Vaccine to Shared Decision-Making
A federal judge has temporarily blocked the change, which a pediatrics group challenged in court.
Updated on Nov. 18, 2026 in Children’s Health

Live Poll
Do you trust federal health officials to make sound childhood vaccine recommendations?
On January 5, federal officials changed the CDC's rotavirus vaccine recommendation for infants to shared decision-making, a shift from routine vaccination the agency has recommended since 2006. The American Academy of Pediatrics sued to reinstate the prior guidance, and a federal judge temporarily blocked the changes.
Why it matters
Current uptake leaves 29% of infants not fully vaccinated against rotavirus, and modeling suggests that lower uptake would lead to more hospitalizations and emergency visits among young children. The dispute centers on whether the change was based on science, a point the judge cited in temporarily halting it.
The modeling projects 1,500 to 4,500 additional hospitalizations and $34.5 to $103.5 million in added healthcare costs per annual birth cohort if uptake falls by 10% to 30%. The study did not consider indirect protection that may reduce rotavirus burden in unvaccinated children by up to 50%.
The players
Centers for Disease Control and Prevention
The CDC is the U.S. federal public health agency responsible for national vaccine recommendations and disease surveillance.
American Academy of Pediatrics
The American Academy of Pediatrics is a professional organization of pediatricians that issues clinical guidance on children's health care.
The details
The change moved rotavirus vaccination to shared decision-making, a category that also applied to several other vaccines. The researchers modeled three scenarios in which 10%, 20% and 30% of infants shift from fully vaccinated to unvaccinated, assuming the new guidance lowers access and uptake. The CDC currently recommends either a two-dose RV1 series (Rotarix) or a three-dose RV5 series (RotaTeq).
Timeline
Since 2006: The CDC began recommending routine rotavirus vaccination for infants.
January 5, 2026: Federal officials changed the recommendation to shared decision-making.
November 18, 2026: Study findings on the guidance change were published in JAMA Network Open.
Big Picture
The January 2026 change departs from the CDC's routine rotavirus vaccination recommendation for infants, which has been in place since 2006. The shift to shared decision-making reverses nearly two decades of universal guidance for this vaccine.
Parents of infants should discuss rotavirus vaccination with a pediatrician, since the recommendation now rests on shared decision-making rather than routine vaccination. Under the temporary court block, the prior guidance remains the subject of litigation and may change again.
The takeaway
Families weighing rotavirus vaccination for infants should review the CDC's current guidance and talk with a pediatric provider about the two available vaccine series. The outcome of the court case may determine which recommendation applies going forward.
Further reading
Explore more on Children’s Health coverage, including vaccine policy and pediatric care.
Source note: This article includes information reported by Healio.
Live Poll
Do you trust federal health officials to make sound childhood vaccine recommendations?






